Global Imatinib Mesylate API Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Imatinib Mesylate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Mesylate API.
The Imatinib Mesylate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Imatinib Mesylate API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imatinib Mesylate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imatinib Mesylate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imatinib Mesylate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Imatinib Mesylate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Imatinib Mesylate API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imatinib Mesylate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Aurobindo Pharma Ltd
- Formosa Laboratories Inc
- Cadila Healthcare Ltd
- Laurus Labs Ltd
- Msn Laboratories Private Ltd
- Intas Pharmaceuticals Ltd
- Zydus Lifesciences Ltd
- Hetero Labs Ltd
- Shilpa Pharma Lifesciences Ltd
- Teva Pharmaceutical Industries Ltd
- Cipla Ltd
- Acebright India Pharma Private Ltd
- Fis Fabbrica Italiana Sintetici Spa
- Dr Reddys Laboratories Ltd
- Natco Pharma Ltd
- Sun Pharmaceutical Industries Ltd
- Reliance Life Sciences Pvt Ltd
- Zhejiang Jiuzhou Pharmaceutical Co Ltd
- Tai Heng Industry Group Co Ltd
- Shandong Anxin Pharmaceutical Co Ltd
- Purity?99%
- Purity<99%
- Tablet
- Capsule
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imatinib Mesylate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imatinib Mesylate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 IMATINIB MESYLATE API MARKET OVERVIEW
1.1 Product Overview and Scope of Imatinib Mesylate API
1.2 Imatinib Mesylate API Segment by Type
1.2.1 Global Imatinib Mesylate API Market Value Comparison by Type (2023-2029)
1.2.2 Purity?99%
1.2.3 Purity<99%
1.3 Imatinib Mesylate API Segment by Application
1.3.1 Global Imatinib Mesylate API Market Value by Application: (2023-2029)
1.3.2 Tablet
1.3.3 Capsule
1.4 Global Imatinib Mesylate API Market Size Estimates and Forecasts
1.4.1 Global Imatinib Mesylate API Revenue 2018-2029
1.4.2 Global Imatinib Mesylate API Sales 2018-2029
1.4.3 Global Imatinib Mesylate API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 IMATINIB MESYLATE API MARKET COMPETITION BY MANUFACTURERS
2.1 Global Imatinib Mesylate API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Imatinib Mesylate API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Imatinib Mesylate API Average Price by Manufacturers (2018-2023)
2.4 Global Imatinib Mesylate API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Imatinib Mesylate API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Imatinib Mesylate API, Product Type & Application
2.7 Imatinib Mesylate API Market Competitive Situation and Trends
2.7.1 Imatinib Mesylate API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Imatinib Mesylate API Players Market Share by Revenue
2.7.3 Global Imatinib Mesylate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IMATINIB MESYLATE API RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Imatinib Mesylate API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Imatinib Mesylate API Global Imatinib Mesylate API Sales by Region: 2018-2029
3.2.1 Global Imatinib Mesylate API Sales by Region: 2018-2023
3.2.2 Global Imatinib Mesylate API Sales by Region: 2024-2029
3.3 Global Imatinib Mesylate API Global Imatinib Mesylate API Revenue by Region: 2018-2029
3.3.1 Global Imatinib Mesylate API Revenue by Region: 2018-2023
3.3.2 Global Imatinib Mesylate API Revenue by Region: 2024-2029
3.4 North America Imatinib Mesylate API Market Facts & Figures by Country
3.4.1 North America Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Imatinib Mesylate API Sales by Country (2018-2029)
3.4.3 North America Imatinib Mesylate API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Imatinib Mesylate API Market Facts & Figures by Country
3.5.1 Europe Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Imatinib Mesylate API Sales by Country (2018-2029)
3.5.3 Europe Imatinib Mesylate API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Imatinib Mesylate API Market Facts & Figures by Country
3.6.1 Asia Pacific Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Imatinib Mesylate API Sales by Country (2018-2029)
3.6.3 Asia Pacific Imatinib Mesylate API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Imatinib Mesylate API Market Facts & Figures by Country
3.7.1 Latin America Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Imatinib Mesylate API Sales by Country (2018-2029)
3.7.3 Latin America Imatinib Mesylate API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Imatinib Mesylate API Market Facts & Figures by Country
3.8.1 Middle East and Africa Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Imatinib Mesylate API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Imatinib Mesylate API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Imatinib Mesylate API Sales by Type (2018-2029)
4.1.1 Global Imatinib Mesylate API Sales by Type (2018-2023)
4.1.2 Global Imatinib Mesylate API Sales by Type (2024-2029)
4.1.3 Global Imatinib Mesylate API Sales Market Share by Type (2018-2029)
4.2 Global Imatinib Mesylate API Revenue by Type (2018-2029)
4.2.1 Global Imatinib Mesylate API Revenue by Type (2018-2023)
4.2.2 Global Imatinib Mesylate API Revenue by Type (2024-2029)
4.2.3 Global Imatinib Mesylate API Revenue Market Share by Type (2018-2029)
4.3 Global Imatinib Mesylate API Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Imatinib Mesylate API Sales by Application (2018-2029)
5.1.1 Global Imatinib Mesylate API Sales by Application (2018-2023)
5.1.2 Global Imatinib Mesylate API Sales by Application (2024-2029)
5.1.3 Global Imatinib Mesylate API Sales Market Share by Application (2018-2029)
5.2 Global Imatinib Mesylate API Revenue by Application (2018-2029)
5.2.1 Global Imatinib Mesylate API Revenue by Application (2018-2023)
5.2.2 Global Imatinib Mesylate API Revenue by Application (2024-2029)
5.2.3 Global Imatinib Mesylate API Revenue Market Share by Application (2018-2029)
5.3 Global Imatinib Mesylate API Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Aurobindo Pharma Ltd
6.1.1 Aurobindo Pharma Ltd Corporation Information
6.1.2 Aurobindo Pharma Ltd Description and Business Overview
6.1.3 Aurobindo Pharma Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aurobindo Pharma Ltd Imatinib Mesylate API Product Portfolio
6.1.5 Aurobindo Pharma Ltd Recent Developments/Updates
6.2 Formosa Laboratories Inc
6.2.1 Formosa Laboratories Inc Corporation Information
6.2.2 Formosa Laboratories Inc Description and Business Overview
6.2.3 Formosa Laboratories Inc Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Formosa Laboratories Inc Imatinib Mesylate API Product Portfolio
6.2.5 Formosa Laboratories Inc Recent Developments/Updates
6.3 Cadila Healthcare Ltd
6.3.1 Cadila Healthcare Ltd Corporation Information
6.3.2 Cadila Healthcare Ltd Description and Business Overview
6.3.3 Cadila Healthcare Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cadila Healthcare Ltd Imatinib Mesylate API Product Portfolio
6.3.5 Cadila Healthcare Ltd Recent Developments/Updates
6.4 Laurus Labs Ltd
6.4.1 Laurus Labs Ltd Corporation Information
6.4.2 Laurus Labs Ltd Description and Business Overview
6.4.3 Laurus Labs Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Laurus Labs Ltd Imatinib Mesylate API Product Portfolio
6.4.5 Laurus Labs Ltd Recent Developments/Updates
6.5 Msn Laboratories Private Ltd
6.5.1 Msn Laboratories Private Ltd Corporation Information
6.5.2 Msn Laboratories Private Ltd Description and Business Overview
6.5.3 Msn Laboratories Private Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Msn Laboratories Private Ltd Imatinib Mesylate API Product Portfolio
6.5.5 Msn Laboratories Private Ltd Recent Developments/Updates
6.6 Intas Pharmaceuticals Ltd
6.6.1 Intas Pharmaceuticals Ltd Corporation Information
6.6.2 Intas Pharmaceuticals Ltd Description and Business Overview
6.6.3 Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Intas Pharmaceuticals Ltd Imatinib Mesylate API Product Portfolio
6.6.5 Intas Pharmaceuticals Ltd Recent Developments/Updates
6.7 Zydus Lifesciences Ltd
6.6.1 Zydus Lifesciences Ltd Corporation Information
6.6.2 Zydus Lifesciences Ltd Description and Business Overview
6.6.3 Zydus Lifesciences Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zydus Lifesciences Ltd Imatinib Mesylate API Product Portfolio
6.7.5 Zydus Lifesciences Ltd Recent Developments/Updates
6.8 Hetero Labs Ltd
6.8.1 Hetero Labs Ltd Corporation Information
6.8.2 Hetero Labs Ltd Description and Business Overview
6.8.3 Hetero Labs Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hetero Labs Ltd Imatinib Mesylate API Product Portfolio
6.8.5 Hetero Labs Ltd Recent Developments/Updates
6.9 Shilpa Pharma Lifesciences Ltd
6.9.1 Shilpa Pharma Lifesciences Ltd Corporation Information
6.9.2 Shilpa Pharma Lifesciences Ltd Description and Business Overview
6.9.3 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product Portfolio
6.9.5 Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
6.10 Teva Pharmaceutical Industries Ltd
6.10.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.10.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolio
6.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.11 Cipla Ltd
6.11.1 Cipla Ltd Corporation Information
6.11.2 Cipla Ltd Imatinib Mesylate API Description and Business Overview
6.11.3 Cipla Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cipla Ltd Imatinib Mesylate API Product Portfolio
6.11.5 Cipla Ltd Recent Developments/Updates
6.12 Acebright India Pharma Private Ltd
6.12.1 Acebright India Pharma Private Ltd Corporation Information
6.12.2 Acebright India Pharma Private Ltd Imatinib Mesylate API Description and Business Overview
6.12.3 Acebright India Pharma Private Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Acebright India Pharma Private Ltd Imatinib Mesylate API Product Portfolio
6.12.5 Acebright India Pharma Private Ltd Recent Developments/Updates
6.13 Fis Fabbrica Italiana Sintetici Spa
6.13.1 Fis Fabbrica Italiana Sintetici Spa Corporation Information
6.13.2 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Description and Business Overview
6.13.3 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product Portfolio
6.13.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
6.14 Dr Reddys Laboratories Ltd
6.14.1 Dr Reddys Laboratories Ltd Corporation Information
6.14.2 Dr Reddys Laboratories Ltd Imatinib Mesylate API Description and Business Overview
6.14.3 Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Dr Reddys Laboratories Ltd Imatinib Mesylate API Product Portfolio
6.14.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
6.15 Natco Pharma Ltd
6.15.1 Natco Pharma Ltd Corporation Information
6.15.2 Natco Pharma Ltd Imatinib Mesylate API Description and Business Overview
6.15.3 Natco Pharma Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Natco Pharma Ltd Imatinib Mesylate API Product Portfolio
6.15.5 Natco Pharma Ltd Recent Developments/Updates
6.16 Sun Pharmaceutical Industries Ltd
6.16.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.16.2 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Description and Business Overview
6.16.3 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolio
6.16.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.17 Reliance Life Sciences Pvt Ltd
6.17.1 Reliance Life Sciences Pvt Ltd Corporation Information
6.17.2 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Description and Business Overview
6.17.3 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product Portfolio
6.17.5 Reliance Life Sciences Pvt Ltd Recent Developments/Updates
6.18 Zhejiang Jiuzhou Pharmaceutical Co Ltd
6.18.1 Zhejiang Jiuzhou Pharmaceutical Co Ltd Corporation Information
6.18.2 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Description and Business Overview
6.18.3 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolio
6.18.5 Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
6.19 Tai Heng Industry Group Co Ltd
6.19.1 Tai Heng Industry Group Co Ltd Corporation Information
6.19.2 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Description and Business Overview
6.19.3 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product Portfolio
6.19.5 Tai Heng Industry Group Co Ltd Recent Developments/Updates
6.20 Shandong Anxin Pharmaceutical Co Ltd
6.20.1 Shandong Anxin Pharmaceutical Co Ltd Corporation Information
6.20.2 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Description and Business Overview
6.20.3 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolio
6.20.5 Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Imatinib Mesylate API Industry Chain Analysis
7.2 Imatinib Mesylate API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Imatinib Mesylate API Production Mode & Process
7.4 Imatinib Mesylate API Sales and Marketing
7.4.1 Imatinib Mesylate API Sales Channels
7.4.2 Imatinib Mesylate API Distributors
7.5 Imatinib Mesylate API Customers
8 IMATINIB MESYLATE API MARKET DYNAMICS
8.1 Imatinib Mesylate API Industry Trends
8.2 Imatinib Mesylate API Market Drivers
8.3 Imatinib Mesylate API Market Challenges
8.4 Imatinib Mesylate API Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Imatinib Mesylate API
1.2 Imatinib Mesylate API Segment by Type
1.2.1 Global Imatinib Mesylate API Market Value Comparison by Type (2023-2029)
1.2.2 Purity?99%
1.2.3 Purity<99%
1.3 Imatinib Mesylate API Segment by Application
1.3.1 Global Imatinib Mesylate API Market Value by Application: (2023-2029)
1.3.2 Tablet
1.3.3 Capsule
1.4 Global Imatinib Mesylate API Market Size Estimates and Forecasts
1.4.1 Global Imatinib Mesylate API Revenue 2018-2029
1.4.2 Global Imatinib Mesylate API Sales 2018-2029
1.4.3 Global Imatinib Mesylate API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 IMATINIB MESYLATE API MARKET COMPETITION BY MANUFACTURERS
2.1 Global Imatinib Mesylate API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Imatinib Mesylate API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Imatinib Mesylate API Average Price by Manufacturers (2018-2023)
2.4 Global Imatinib Mesylate API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Imatinib Mesylate API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Imatinib Mesylate API, Product Type & Application
2.7 Imatinib Mesylate API Market Competitive Situation and Trends
2.7.1 Imatinib Mesylate API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Imatinib Mesylate API Players Market Share by Revenue
2.7.3 Global Imatinib Mesylate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IMATINIB MESYLATE API RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Imatinib Mesylate API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Imatinib Mesylate API Global Imatinib Mesylate API Sales by Region: 2018-2029
3.2.1 Global Imatinib Mesylate API Sales by Region: 2018-2023
3.2.2 Global Imatinib Mesylate API Sales by Region: 2024-2029
3.3 Global Imatinib Mesylate API Global Imatinib Mesylate API Revenue by Region: 2018-2029
3.3.1 Global Imatinib Mesylate API Revenue by Region: 2018-2023
3.3.2 Global Imatinib Mesylate API Revenue by Region: 2024-2029
3.4 North America Imatinib Mesylate API Market Facts & Figures by Country
3.4.1 North America Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Imatinib Mesylate API Sales by Country (2018-2029)
3.4.3 North America Imatinib Mesylate API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Imatinib Mesylate API Market Facts & Figures by Country
3.5.1 Europe Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Imatinib Mesylate API Sales by Country (2018-2029)
3.5.3 Europe Imatinib Mesylate API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Imatinib Mesylate API Market Facts & Figures by Country
3.6.1 Asia Pacific Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Imatinib Mesylate API Sales by Country (2018-2029)
3.6.3 Asia Pacific Imatinib Mesylate API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Imatinib Mesylate API Market Facts & Figures by Country
3.7.1 Latin America Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Imatinib Mesylate API Sales by Country (2018-2029)
3.7.3 Latin America Imatinib Mesylate API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Imatinib Mesylate API Market Facts & Figures by Country
3.8.1 Middle East and Africa Imatinib Mesylate API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Imatinib Mesylate API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Imatinib Mesylate API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Imatinib Mesylate API Sales by Type (2018-2029)
4.1.1 Global Imatinib Mesylate API Sales by Type (2018-2023)
4.1.2 Global Imatinib Mesylate API Sales by Type (2024-2029)
4.1.3 Global Imatinib Mesylate API Sales Market Share by Type (2018-2029)
4.2 Global Imatinib Mesylate API Revenue by Type (2018-2029)
4.2.1 Global Imatinib Mesylate API Revenue by Type (2018-2023)
4.2.2 Global Imatinib Mesylate API Revenue by Type (2024-2029)
4.2.3 Global Imatinib Mesylate API Revenue Market Share by Type (2018-2029)
4.3 Global Imatinib Mesylate API Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Imatinib Mesylate API Sales by Application (2018-2029)
5.1.1 Global Imatinib Mesylate API Sales by Application (2018-2023)
5.1.2 Global Imatinib Mesylate API Sales by Application (2024-2029)
5.1.3 Global Imatinib Mesylate API Sales Market Share by Application (2018-2029)
5.2 Global Imatinib Mesylate API Revenue by Application (2018-2029)
5.2.1 Global Imatinib Mesylate API Revenue by Application (2018-2023)
5.2.2 Global Imatinib Mesylate API Revenue by Application (2024-2029)
5.2.3 Global Imatinib Mesylate API Revenue Market Share by Application (2018-2029)
5.3 Global Imatinib Mesylate API Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Aurobindo Pharma Ltd
6.1.1 Aurobindo Pharma Ltd Corporation Information
6.1.2 Aurobindo Pharma Ltd Description and Business Overview
6.1.3 Aurobindo Pharma Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aurobindo Pharma Ltd Imatinib Mesylate API Product Portfolio
6.1.5 Aurobindo Pharma Ltd Recent Developments/Updates
6.2 Formosa Laboratories Inc
6.2.1 Formosa Laboratories Inc Corporation Information
6.2.2 Formosa Laboratories Inc Description and Business Overview
6.2.3 Formosa Laboratories Inc Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Formosa Laboratories Inc Imatinib Mesylate API Product Portfolio
6.2.5 Formosa Laboratories Inc Recent Developments/Updates
6.3 Cadila Healthcare Ltd
6.3.1 Cadila Healthcare Ltd Corporation Information
6.3.2 Cadila Healthcare Ltd Description and Business Overview
6.3.3 Cadila Healthcare Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cadila Healthcare Ltd Imatinib Mesylate API Product Portfolio
6.3.5 Cadila Healthcare Ltd Recent Developments/Updates
6.4 Laurus Labs Ltd
6.4.1 Laurus Labs Ltd Corporation Information
6.4.2 Laurus Labs Ltd Description and Business Overview
6.4.3 Laurus Labs Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Laurus Labs Ltd Imatinib Mesylate API Product Portfolio
6.4.5 Laurus Labs Ltd Recent Developments/Updates
6.5 Msn Laboratories Private Ltd
6.5.1 Msn Laboratories Private Ltd Corporation Information
6.5.2 Msn Laboratories Private Ltd Description and Business Overview
6.5.3 Msn Laboratories Private Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Msn Laboratories Private Ltd Imatinib Mesylate API Product Portfolio
6.5.5 Msn Laboratories Private Ltd Recent Developments/Updates
6.6 Intas Pharmaceuticals Ltd
6.6.1 Intas Pharmaceuticals Ltd Corporation Information
6.6.2 Intas Pharmaceuticals Ltd Description and Business Overview
6.6.3 Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Intas Pharmaceuticals Ltd Imatinib Mesylate API Product Portfolio
6.6.5 Intas Pharmaceuticals Ltd Recent Developments/Updates
6.7 Zydus Lifesciences Ltd
6.6.1 Zydus Lifesciences Ltd Corporation Information
6.6.2 Zydus Lifesciences Ltd Description and Business Overview
6.6.3 Zydus Lifesciences Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zydus Lifesciences Ltd Imatinib Mesylate API Product Portfolio
6.7.5 Zydus Lifesciences Ltd Recent Developments/Updates
6.8 Hetero Labs Ltd
6.8.1 Hetero Labs Ltd Corporation Information
6.8.2 Hetero Labs Ltd Description and Business Overview
6.8.3 Hetero Labs Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hetero Labs Ltd Imatinib Mesylate API Product Portfolio
6.8.5 Hetero Labs Ltd Recent Developments/Updates
6.9 Shilpa Pharma Lifesciences Ltd
6.9.1 Shilpa Pharma Lifesciences Ltd Corporation Information
6.9.2 Shilpa Pharma Lifesciences Ltd Description and Business Overview
6.9.3 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product Portfolio
6.9.5 Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
6.10 Teva Pharmaceutical Industries Ltd
6.10.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.10.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolio
6.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.11 Cipla Ltd
6.11.1 Cipla Ltd Corporation Information
6.11.2 Cipla Ltd Imatinib Mesylate API Description and Business Overview
6.11.3 Cipla Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cipla Ltd Imatinib Mesylate API Product Portfolio
6.11.5 Cipla Ltd Recent Developments/Updates
6.12 Acebright India Pharma Private Ltd
6.12.1 Acebright India Pharma Private Ltd Corporation Information
6.12.2 Acebright India Pharma Private Ltd Imatinib Mesylate API Description and Business Overview
6.12.3 Acebright India Pharma Private Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Acebright India Pharma Private Ltd Imatinib Mesylate API Product Portfolio
6.12.5 Acebright India Pharma Private Ltd Recent Developments/Updates
6.13 Fis Fabbrica Italiana Sintetici Spa
6.13.1 Fis Fabbrica Italiana Sintetici Spa Corporation Information
6.13.2 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Description and Business Overview
6.13.3 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product Portfolio
6.13.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
6.14 Dr Reddys Laboratories Ltd
6.14.1 Dr Reddys Laboratories Ltd Corporation Information
6.14.2 Dr Reddys Laboratories Ltd Imatinib Mesylate API Description and Business Overview
6.14.3 Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Dr Reddys Laboratories Ltd Imatinib Mesylate API Product Portfolio
6.14.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
6.15 Natco Pharma Ltd
6.15.1 Natco Pharma Ltd Corporation Information
6.15.2 Natco Pharma Ltd Imatinib Mesylate API Description and Business Overview
6.15.3 Natco Pharma Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Natco Pharma Ltd Imatinib Mesylate API Product Portfolio
6.15.5 Natco Pharma Ltd Recent Developments/Updates
6.16 Sun Pharmaceutical Industries Ltd
6.16.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.16.2 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Description and Business Overview
6.16.3 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolio
6.16.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.17 Reliance Life Sciences Pvt Ltd
6.17.1 Reliance Life Sciences Pvt Ltd Corporation Information
6.17.2 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Description and Business Overview
6.17.3 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product Portfolio
6.17.5 Reliance Life Sciences Pvt Ltd Recent Developments/Updates
6.18 Zhejiang Jiuzhou Pharmaceutical Co Ltd
6.18.1 Zhejiang Jiuzhou Pharmaceutical Co Ltd Corporation Information
6.18.2 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Description and Business Overview
6.18.3 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolio
6.18.5 Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
6.19 Tai Heng Industry Group Co Ltd
6.19.1 Tai Heng Industry Group Co Ltd Corporation Information
6.19.2 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Description and Business Overview
6.19.3 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product Portfolio
6.19.5 Tai Heng Industry Group Co Ltd Recent Developments/Updates
6.20 Shandong Anxin Pharmaceutical Co Ltd
6.20.1 Shandong Anxin Pharmaceutical Co Ltd Corporation Information
6.20.2 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Description and Business Overview
6.20.3 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolio
6.20.5 Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Imatinib Mesylate API Industry Chain Analysis
7.2 Imatinib Mesylate API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Imatinib Mesylate API Production Mode & Process
7.4 Imatinib Mesylate API Sales and Marketing
7.4.1 Imatinib Mesylate API Sales Channels
7.4.2 Imatinib Mesylate API Distributors
7.5 Imatinib Mesylate API Customers
8 IMATINIB MESYLATE API MARKET DYNAMICS
8.1 Imatinib Mesylate API Industry Trends
8.2 Imatinib Mesylate API Market Drivers
8.3 Imatinib Mesylate API Market Challenges
8.4 Imatinib Mesylate API Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Imatinib Mesylate API Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Imatinib Mesylate API Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Imatinib Mesylate API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Imatinib Mesylate API Sales (Tons) of Key Manufacturers (2018-2023)
Table 5. Global Imatinib Mesylate API Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Imatinib Mesylate API Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Imatinib Mesylate API Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Imatinib Mesylate API Average Price (US$/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Imatinib Mesylate API, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Imatinib Mesylate API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Imatinib Mesylate API, Product Type & Application
Table 12. Global Key Manufacturers of Imatinib Mesylate API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Imatinib Mesylate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Imatinib Mesylate API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Imatinib Mesylate API Sales by Region (2018-2023) & (Tons)
Table 18. Global Imatinib Mesylate API Sales Market Share by Region (2018-2023)
Table 19. Global Imatinib Mesylate API Sales by Region (2024-2029) & (Tons)
Table 20. Global Imatinib Mesylate API Sales Market Share by Region (2024-2029)
Table 21. Global Imatinib Mesylate API Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Imatinib Mesylate API Revenue Market Share by Region (2018-2023)
Table 23. Global Imatinib Mesylate API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Imatinib Mesylate API Revenue Market Share by Region (2024-2029)
Table 25. North America Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 27. North America Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 28. North America Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 32. Europe Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 33. Europe Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Imatinib Mesylate API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Imatinib Mesylate API Sales by Region (2018-2023) & (Tons)
Table 37. Asia Pacific Imatinib Mesylate API Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Imatinib Mesylate API Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Imatinib Mesylate API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 42. Latin America Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 47. Middle East & Africa Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Imatinib Mesylate API Sales (Tons) by Type (2018-2023)
Table 51. Global Imatinib Mesylate API Sales (Tons) by Type (2024-2029)
Table 52. Global Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Table 53. Global Imatinib Mesylate API Sales Market Share by Type (2024-2029)
Table 54. Global Imatinib Mesylate API Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Imatinib Mesylate API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Imatinib Mesylate API Revenue Market Share by Type (2018-2023)
Table 57. Global Imatinib Mesylate API Revenue Market Share by Type (2024-2029)
Table 58. Global Imatinib Mesylate API Price (US$/Ton) by Type (2018-2023)
Table 59. Global Imatinib Mesylate API Price (US$/Ton) by Type (2024-2029)
Table 60. Global Imatinib Mesylate API Sales (Tons) by Application (2018-2023)
Table 61. Global Imatinib Mesylate API Sales (Tons) by Application (2024-2029)
Table 62. Global Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Table 63. Global Imatinib Mesylate API Sales Market Share by Application (2024-2029)
Table 64. Global Imatinib Mesylate API Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Imatinib Mesylate API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Imatinib Mesylate API Revenue Market Share by Application (2018-2023)
Table 67. Global Imatinib Mesylate API Revenue Market Share by Application (2024-2029)
Table 68. Global Imatinib Mesylate API Price (US$/Ton) by Application (2018-2023)
Table 69. Global Imatinib Mesylate API Price (US$/Ton) by Application (2024-2029)
Table 70. Aurobindo Pharma Ltd Corporation Information
Table 71. Aurobindo Pharma Ltd Description and Business Overview
Table 72. Aurobindo Pharma Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 73. Aurobindo Pharma Ltd Imatinib Mesylate API Product
Table 74. Aurobindo Pharma Ltd Recent Developments/Updates
Table 75. Formosa Laboratories Inc Corporation Information
Table 76. Formosa Laboratories Inc Description and Business Overview
Table 77. Formosa Laboratories Inc Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 78. Formosa Laboratories Inc Imatinib Mesylate API Product
Table 79. Formosa Laboratories Inc Recent Developments/Updates
Table 80. Cadila Healthcare Ltd Corporation Information
Table 81. Cadila Healthcare Ltd Description and Business Overview
Table 82. Cadila Healthcare Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. Cadila Healthcare Ltd Imatinib Mesylate API Product
Table 84. Cadila Healthcare Ltd Recent Developments/Updates
Table 85. Laurus Labs Ltd Corporation Information
Table 86. Laurus Labs Ltd Description and Business Overview
Table 87. Laurus Labs Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Laurus Labs Ltd Imatinib Mesylate API Product
Table 89. Laurus Labs Ltd Recent Developments/Updates
Table 90. Msn Laboratories Private Ltd Corporation Information
Table 91. Msn Laboratories Private Ltd Description and Business Overview
Table 92. Msn Laboratories Private Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Msn Laboratories Private Ltd Imatinib Mesylate API Product
Table 94. Msn Laboratories Private Ltd Recent Developments/Updates
Table 95. Intas Pharmaceuticals Ltd Corporation Information
Table 96. Intas Pharmaceuticals Ltd Description and Business Overview
Table 97. Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. Intas Pharmaceuticals Ltd Imatinib Mesylate API Product
Table 99. Intas Pharmaceuticals Ltd Recent Developments/Updates
Table 100. Zydus Lifesciences Ltd Corporation Information
Table 101. Zydus Lifesciences Ltd Description and Business Overview
Table 102. Zydus Lifesciences Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Zydus Lifesciences Ltd Imatinib Mesylate API Product
Table 104. Zydus Lifesciences Ltd Recent Developments/Updates
Table 105. Hetero Labs Ltd Corporation Information
Table 106. Hetero Labs Ltd Description and Business Overview
Table 107. Hetero Labs Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 108. Hetero Labs Ltd Imatinib Mesylate API Product
Table 109. Hetero Labs Ltd Recent Developments/Updates
Table 110. Shilpa Pharma Lifesciences Ltd Corporation Information
Table 111. Shilpa Pharma Lifesciences Ltd Description and Business Overview
Table 112. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 113. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product
Table 114. Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Ltd Corporation Information
Table 116. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 117. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product
Table 119. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Cipla Ltd Corporation Information
Table 121. Cipla Ltd Description and Business Overview
Table 122. Cipla Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Cipla Ltd Imatinib Mesylate API Product
Table 124. Cipla Ltd Recent Developments/Updates
Table 125. Acebright India Pharma Private Ltd Corporation Information
Table 126. Acebright India Pharma Private Ltd Description and Business Overview
Table 127. Acebright India Pharma Private Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 128. Acebright India Pharma Private Ltd Imatinib Mesylate API Product
Table 129. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 130. Fis Fabbrica Italiana Sintetici Spa Corporation Information
Table 131. Fis Fabbrica Italiana Sintetici Spa Description and Business Overview
Table 132. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 133. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product
Table 134. Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
Table 135. Dr Reddys Laboratories Ltd Corporation Information
Table 136. Dr Reddys Laboratories Ltd Description and Business Overview
Table 137. Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 138. Dr Reddys Laboratories Ltd Imatinib Mesylate API Product
Table 139. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 140. Natco Pharma Ltd Corporation Information
Table 141. Natco Pharma Ltd Description and Business Overview
Table 142. Natco Pharma Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 143. Natco Pharma Ltd Imatinib Mesylate API Product
Table 144. Natco Pharma Ltd Recent Developments/Updates
Table 145. Sun Pharmaceutical Industries Ltd Corporation Information
Table 146. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 147. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 148. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product
Table 149. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 150. Reliance Life Sciences Pvt Ltd Corporation Information
Table 151. Reliance Life Sciences Pvt Ltd Description and Business Overview
Table 152. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 153. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product
Table 154. Reliance Life Sciences Pvt Ltd Recent Developments/Updates
Table 155. Zhejiang Jiuzhou Pharmaceutical Co Ltd Corporation Information
Table 156. Zhejiang Jiuzhou Pharmaceutical Co Ltd Description and Business Overview
Table 157. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 158. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product
Table 159. Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
Table 160. Tai Heng Industry Group Co Ltd Corporation Information
Table 161. Tai Heng Industry Group Co Ltd Description and Business Overview
Table 162. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 163. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product
Table 164. Tai Heng Industry Group Co Ltd Recent Developments/Updates
Table 165. Shandong Anxin Pharmaceutical Co Ltd Corporation Information
Table 166. Shandong Anxin Pharmaceutical Co Ltd Description and Business Overview
Table 167. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 168. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product
Table 169. Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Imatinib Mesylate API Distributors List
Table 173. Imatinib Mesylate API Customers List
Table 174. Imatinib Mesylate API Market Trends
Table 175. Imatinib Mesylate API Market Drivers
Table 176. Imatinib Mesylate API Market Challenges
Table 177. Imatinib Mesylate API Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 1. Global Imatinib Mesylate API Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Imatinib Mesylate API Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Imatinib Mesylate API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Imatinib Mesylate API Sales (Tons) of Key Manufacturers (2018-2023)
Table 5. Global Imatinib Mesylate API Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Imatinib Mesylate API Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Imatinib Mesylate API Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Imatinib Mesylate API Average Price (US$/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Imatinib Mesylate API, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Imatinib Mesylate API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Imatinib Mesylate API, Product Type & Application
Table 12. Global Key Manufacturers of Imatinib Mesylate API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Imatinib Mesylate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Imatinib Mesylate API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Imatinib Mesylate API Sales by Region (2018-2023) & (Tons)
Table 18. Global Imatinib Mesylate API Sales Market Share by Region (2018-2023)
Table 19. Global Imatinib Mesylate API Sales by Region (2024-2029) & (Tons)
Table 20. Global Imatinib Mesylate API Sales Market Share by Region (2024-2029)
Table 21. Global Imatinib Mesylate API Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Imatinib Mesylate API Revenue Market Share by Region (2018-2023)
Table 23. Global Imatinib Mesylate API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Imatinib Mesylate API Revenue Market Share by Region (2024-2029)
Table 25. North America Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 27. North America Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 28. North America Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 32. Europe Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 33. Europe Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Imatinib Mesylate API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Imatinib Mesylate API Sales by Region (2018-2023) & (Tons)
Table 37. Asia Pacific Imatinib Mesylate API Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Imatinib Mesylate API Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Imatinib Mesylate API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 42. Latin America Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Imatinib Mesylate API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 47. Middle East & Africa Imatinib Mesylate API Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Imatinib Mesylate API Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Imatinib Mesylate API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Imatinib Mesylate API Sales (Tons) by Type (2018-2023)
Table 51. Global Imatinib Mesylate API Sales (Tons) by Type (2024-2029)
Table 52. Global Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Table 53. Global Imatinib Mesylate API Sales Market Share by Type (2024-2029)
Table 54. Global Imatinib Mesylate API Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Imatinib Mesylate API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Imatinib Mesylate API Revenue Market Share by Type (2018-2023)
Table 57. Global Imatinib Mesylate API Revenue Market Share by Type (2024-2029)
Table 58. Global Imatinib Mesylate API Price (US$/Ton) by Type (2018-2023)
Table 59. Global Imatinib Mesylate API Price (US$/Ton) by Type (2024-2029)
Table 60. Global Imatinib Mesylate API Sales (Tons) by Application (2018-2023)
Table 61. Global Imatinib Mesylate API Sales (Tons) by Application (2024-2029)
Table 62. Global Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Table 63. Global Imatinib Mesylate API Sales Market Share by Application (2024-2029)
Table 64. Global Imatinib Mesylate API Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Imatinib Mesylate API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Imatinib Mesylate API Revenue Market Share by Application (2018-2023)
Table 67. Global Imatinib Mesylate API Revenue Market Share by Application (2024-2029)
Table 68. Global Imatinib Mesylate API Price (US$/Ton) by Application (2018-2023)
Table 69. Global Imatinib Mesylate API Price (US$/Ton) by Application (2024-2029)
Table 70. Aurobindo Pharma Ltd Corporation Information
Table 71. Aurobindo Pharma Ltd Description and Business Overview
Table 72. Aurobindo Pharma Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 73. Aurobindo Pharma Ltd Imatinib Mesylate API Product
Table 74. Aurobindo Pharma Ltd Recent Developments/Updates
Table 75. Formosa Laboratories Inc Corporation Information
Table 76. Formosa Laboratories Inc Description and Business Overview
Table 77. Formosa Laboratories Inc Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 78. Formosa Laboratories Inc Imatinib Mesylate API Product
Table 79. Formosa Laboratories Inc Recent Developments/Updates
Table 80. Cadila Healthcare Ltd Corporation Information
Table 81. Cadila Healthcare Ltd Description and Business Overview
Table 82. Cadila Healthcare Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. Cadila Healthcare Ltd Imatinib Mesylate API Product
Table 84. Cadila Healthcare Ltd Recent Developments/Updates
Table 85. Laurus Labs Ltd Corporation Information
Table 86. Laurus Labs Ltd Description and Business Overview
Table 87. Laurus Labs Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Laurus Labs Ltd Imatinib Mesylate API Product
Table 89. Laurus Labs Ltd Recent Developments/Updates
Table 90. Msn Laboratories Private Ltd Corporation Information
Table 91. Msn Laboratories Private Ltd Description and Business Overview
Table 92. Msn Laboratories Private Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Msn Laboratories Private Ltd Imatinib Mesylate API Product
Table 94. Msn Laboratories Private Ltd Recent Developments/Updates
Table 95. Intas Pharmaceuticals Ltd Corporation Information
Table 96. Intas Pharmaceuticals Ltd Description and Business Overview
Table 97. Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. Intas Pharmaceuticals Ltd Imatinib Mesylate API Product
Table 99. Intas Pharmaceuticals Ltd Recent Developments/Updates
Table 100. Zydus Lifesciences Ltd Corporation Information
Table 101. Zydus Lifesciences Ltd Description and Business Overview
Table 102. Zydus Lifesciences Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Zydus Lifesciences Ltd Imatinib Mesylate API Product
Table 104. Zydus Lifesciences Ltd Recent Developments/Updates
Table 105. Hetero Labs Ltd Corporation Information
Table 106. Hetero Labs Ltd Description and Business Overview
Table 107. Hetero Labs Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 108. Hetero Labs Ltd Imatinib Mesylate API Product
Table 109. Hetero Labs Ltd Recent Developments/Updates
Table 110. Shilpa Pharma Lifesciences Ltd Corporation Information
Table 111. Shilpa Pharma Lifesciences Ltd Description and Business Overview
Table 112. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 113. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product
Table 114. Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Ltd Corporation Information
Table 116. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 117. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product
Table 119. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Cipla Ltd Corporation Information
Table 121. Cipla Ltd Description and Business Overview
Table 122. Cipla Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Cipla Ltd Imatinib Mesylate API Product
Table 124. Cipla Ltd Recent Developments/Updates
Table 125. Acebright India Pharma Private Ltd Corporation Information
Table 126. Acebright India Pharma Private Ltd Description and Business Overview
Table 127. Acebright India Pharma Private Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 128. Acebright India Pharma Private Ltd Imatinib Mesylate API Product
Table 129. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 130. Fis Fabbrica Italiana Sintetici Spa Corporation Information
Table 131. Fis Fabbrica Italiana Sintetici Spa Description and Business Overview
Table 132. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 133. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product
Table 134. Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
Table 135. Dr Reddys Laboratories Ltd Corporation Information
Table 136. Dr Reddys Laboratories Ltd Description and Business Overview
Table 137. Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 138. Dr Reddys Laboratories Ltd Imatinib Mesylate API Product
Table 139. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 140. Natco Pharma Ltd Corporation Information
Table 141. Natco Pharma Ltd Description and Business Overview
Table 142. Natco Pharma Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 143. Natco Pharma Ltd Imatinib Mesylate API Product
Table 144. Natco Pharma Ltd Recent Developments/Updates
Table 145. Sun Pharmaceutical Industries Ltd Corporation Information
Table 146. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 147. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 148. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product
Table 149. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 150. Reliance Life Sciences Pvt Ltd Corporation Information
Table 151. Reliance Life Sciences Pvt Ltd Description and Business Overview
Table 152. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 153. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product
Table 154. Reliance Life Sciences Pvt Ltd Recent Developments/Updates
Table 155. Zhejiang Jiuzhou Pharmaceutical Co Ltd Corporation Information
Table 156. Zhejiang Jiuzhou Pharmaceutical Co Ltd Description and Business Overview
Table 157. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 158. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product
Table 159. Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
Table 160. Tai Heng Industry Group Co Ltd Corporation Information
Table 161. Tai Heng Industry Group Co Ltd Description and Business Overview
Table 162. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 163. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product
Table 164. Tai Heng Industry Group Co Ltd Recent Developments/Updates
Table 165. Shandong Anxin Pharmaceutical Co Ltd Corporation Information
Table 166. Shandong Anxin Pharmaceutical Co Ltd Description and Business Overview
Table 167. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 168. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product
Table 169. Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Imatinib Mesylate API Distributors List
Table 173. Imatinib Mesylate API Customers List
Table 174. Imatinib Mesylate API Market Trends
Table 175. Imatinib Mesylate API Market Drivers
Table 176. Imatinib Mesylate API Market Challenges
Table 177. Imatinib Mesylate API Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Imatinib Mesylate API
Figure 2. Global Imatinib Mesylate API Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Imatinib Mesylate API Market Share by Type in 2022 & 2029
Figure 4. Purity?99% Product Picture
Figure 5. Purity<99% Product Picture
Figure 6. Global Imatinib Mesylate API Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Imatinib Mesylate API Market Share by Application in 2022 & 2029
Figure 8. Tablet
Figure 9. Capsule
Figure 10. Global Imatinib Mesylate API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Imatinib Mesylate API Market Size (2018-2029) & (US$ Million)
Figure 12. Global Imatinib Mesylate API Sales (2018-2029) & (Tons)
Figure 13. Global Imatinib Mesylate API Average Price (US$/Ton) & (2018-2029)
Figure 14. Imatinib Mesylate API Report Years Considered
Figure 15. Imatinib Mesylate API Sales Share by Manufacturers in 2022
Figure 16. Global Imatinib Mesylate API Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Imatinib Mesylate API Players: Market Share by Revenue in 2022
Figure 18. Imatinib Mesylate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Imatinib Mesylate API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 21. North America Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 22. United States Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 25. Europe Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 26. Germany Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Imatinib Mesylate API Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Imatinib Mesylate API Revenue Market Share by Region (2018-2029)
Figure 33. China Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 41. Latin America Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Colombia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Imatinib Mesylate API by Type (2018-2029)
Figure 52. Global Revenue Market Share of Imatinib Mesylate API by Type (2018-2029)
Figure 53. Global Imatinib Mesylate API Price (US$/Ton) by Type (2018-2029)
Figure 54. Global Sales Market Share of Imatinib Mesylate API by Application (2018-2029)
Figure 55. Global Revenue Market Share of Imatinib Mesylate API by Application (2018-2029)
Figure 56. Global Imatinib Mesylate API Price (US$/Ton) by Application (2018-2029)
Figure 57. Imatinib Mesylate API Value Chain
Figure 58. Imatinib Mesylate API Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Product Picture of Imatinib Mesylate API
Figure 2. Global Imatinib Mesylate API Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Imatinib Mesylate API Market Share by Type in 2022 & 2029
Figure 4. Purity?99% Product Picture
Figure 5. Purity<99% Product Picture
Figure 6. Global Imatinib Mesylate API Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Imatinib Mesylate API Market Share by Application in 2022 & 2029
Figure 8. Tablet
Figure 9. Capsule
Figure 10. Global Imatinib Mesylate API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Imatinib Mesylate API Market Size (2018-2029) & (US$ Million)
Figure 12. Global Imatinib Mesylate API Sales (2018-2029) & (Tons)
Figure 13. Global Imatinib Mesylate API Average Price (US$/Ton) & (2018-2029)
Figure 14. Imatinib Mesylate API Report Years Considered
Figure 15. Imatinib Mesylate API Sales Share by Manufacturers in 2022
Figure 16. Global Imatinib Mesylate API Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Imatinib Mesylate API Players: Market Share by Revenue in 2022
Figure 18. Imatinib Mesylate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Imatinib Mesylate API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 21. North America Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 22. United States Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 25. Europe Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 26. Germany Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Imatinib Mesylate API Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Imatinib Mesylate API Revenue Market Share by Region (2018-2029)
Figure 33. China Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 41. Latin America Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Colombia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Imatinib Mesylate API Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Imatinib Mesylate API Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Imatinib Mesylate API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Imatinib Mesylate API by Type (2018-2029)
Figure 52. Global Revenue Market Share of Imatinib Mesylate API by Type (2018-2029)
Figure 53. Global Imatinib Mesylate API Price (US$/Ton) by Type (2018-2029)
Figure 54. Global Sales Market Share of Imatinib Mesylate API by Application (2018-2029)
Figure 55. Global Revenue Market Share of Imatinib Mesylate API by Application (2018-2029)
Figure 56. Global Imatinib Mesylate API Price (US$/Ton) by Application (2018-2029)
Figure 57. Imatinib Mesylate API Value Chain
Figure 58. Imatinib Mesylate API Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
